JPY 4440.0
(0.57%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 24.79 Billion JPY | 5.11% |
2022 | 23.37 Billion JPY | -3.95% |
2021 | 24.33 Billion JPY | 11.97% |
2020 | 21.73 Billion JPY | -2.5% |
2019 | 22.29 Billion JPY | -27.39% |
2018 | 30.7 Billion JPY | -6.5% |
2017 | 32.84 Billion JPY | 9.76% |
2016 | 29.92 Billion JPY | -5.21% |
2015 | 31.56 Billion JPY | 37.74% |
2014 | 22.91 Billion JPY | -28.03% |
2013 | 31.84 Billion JPY | 8.11% |
2012 | 29.45 Billion JPY | 4.52% |
2011 | 28.17 Billion JPY | 5.41% |
2010 | 26.73 Billion JPY | 1.14% |
2009 | 26.43 Billion JPY | 11.53% |
2008 | 23.7 Billion JPY | -3.64% |
2007 | 24.59 Billion JPY | 1.62% |
2006 | 24.2 Billion JPY | -5.39% |
2005 | 25.58 Billion JPY | -2.75% |
2004 | 26.3 Billion JPY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q3 | 6.79 Billion JPY | 2.23% |
2024 Q2 | 6.64 Billion JPY | 11.4% |
2024 Q1 | 5.96 Billion JPY | -11.74% |
2023 Q3 | 6.1 Billion JPY | -4.7% |
2023 FY | 24.57 Billion JPY | 5.11% |
2023 Q4 | 6.75 Billion JPY | 10.68% |
2023 Q2 | 6.4 Billion JPY | 15.99% |
2023 Q1 | 5.52 Billion JPY | -14.46% |
2022 Q3 | 5.86 Billion JPY | 1.77% |
2022 Q2 | 5.76 Billion JPY | 9.06% |
2022 FY | 23.37 Billion JPY | -3.95% |
2022 Q1 | 5.28 Billion JPY | -25.45% |
2022 Q4 | 6.45 Billion JPY | 10.04% |
2021 FY | 24.33 Billion JPY | 11.97% |
2021 Q4 | 7.09 Billion JPY | 14.68% |
2021 Q1 | 5.1 Billion JPY | -16.52% |
2021 Q2 | 5.95 Billion JPY | 16.75% |
2021 Q3 | 6.18 Billion JPY | 3.78% |
2020 Q4 | 6.11 Billion JPY | 16.59% |
2020 Q1 | 5.12 Billion JPY | -11.99% |
2020 Q2 | 5.25 Billion JPY | 2.66% |
2020 Q3 | 5.24 Billion JPY | -0.27% |
2020 FY | 21.73 Billion JPY | -2.5% |
2019 Q3 | 5.57 Billion JPY | -9.07% |
2019 Q4 | 5.82 Billion JPY | 4.39% |
2019 FY | 22.29 Billion JPY | -27.39% |
2019 Q1 | 4.76 Billion JPY | -45.25% |
2019 Q2 | 6.13 Billion JPY | 28.56% |
2018 Q3 | 7.28 Billion JPY | -5.92% |
2018 FY | 30.7 Billion JPY | -6.5% |
2018 Q1 | 6.97 Billion JPY | -28.21% |
2018 Q4 | 8.71 Billion JPY | 19.63% |
2018 Q2 | 7.73 Billion JPY | 10.94% |
2017 Q2 | 8.51 Billion JPY | 25.05% |
2017 FY | 32.84 Billion JPY | 9.76% |
2017 Q4 | 9.71 Billion JPY | 24.47% |
2017 Q3 | 7.8 Billion JPY | -8.27% |
2017 Q1 | 6.8 Billion JPY | -15.02% |
2016 Q2 | 7.59 Billion JPY | 4.51% |
2016 Q1 | 7.26 Billion JPY | -17.7% |
2016 FY | 29.92 Billion JPY | -5.21% |
2016 Q4 | 8 Billion JPY | 13.55% |
2016 Q3 | 7.05 Billion JPY | -7.11% |
2015 FY | 31.56 Billion JPY | 37.74% |
2015 Q4 | 8.82 Billion JPY | 18.29% |
2015 Q3 | 7.46 Billion JPY | -10.9% |
2015 Q2 | 8.37 Billion JPY | 21.38% |
2015 Q1 | 6.9 Billion JPY | 0.0% |
2014 Q3 | 7.76 Billion JPY | 16.77% |
2014 Q1 | 7.77 Billion JPY | -7.25% |
2014 FY | 22.91 Billion JPY | -28.03% |
2014 Q2 | 6.65 Billion JPY | -14.43% |
2013 Q4 | 8.38 Billion JPY | 6.17% |
2013 FY | 31.84 Billion JPY | 8.11% |
2013 Q1 | 6.49 Billion JPY | -18.8% |
2013 Q2 | 7.78 Billion JPY | 19.89% |
2013 Q3 | 7.89 Billion JPY | 1.39% |
2012 Q4 | 8 Billion JPY | 7.92% |
2012 FY | 29.45 Billion JPY | 4.52% |
2012 Q1 | 6.15 Billion JPY | -22.61% |
2012 Q2 | 7.54 Billion JPY | 22.53% |
2012 Q3 | 7.41 Billion JPY | -1.72% |
2011 FY | 28.17 Billion JPY | 5.41% |
2011 Q2 | 6.94 Billion JPY | 11.43% |
2011 Q3 | 7.12 Billion JPY | 2.64% |
2011 Q4 | 7.95 Billion JPY | 11.65% |
2011 Q1 | 6.23 Billion JPY | -12.87% |
2010 Q2 | 6.74 Billion JPY | 20.5% |
2010 FY | 26.73 Billion JPY | 1.14% |
2010 Q4 | 7.15 Billion JPY | 8.28% |
2010 Q3 | 6.6 Billion JPY | -2.16% |
2010 Q1 | 5.6 Billion JPY | -23.34% |
2009 Q1 | 5.18 Billion JPY | -22.91% |
2009 Q2 | 6.73 Billion JPY | 30.03% |
2009 Q3 | 6.78 Billion JPY | 0.73% |
2009 Q4 | 7.3 Billion JPY | 7.65% |
2009 FY | 26.43 Billion JPY | 11.53% |
2008 Q4 | 6.72 Billion JPY | 14.49% |
2008 Q3 | 5.87 Billion JPY | 0.0% |
2008 FY | 23.7 Billion JPY | -3.64% |
2007 FY | 24.59 Billion JPY | 1.62% |
2006 FY | 24.2 Billion JPY | -5.39% |
2005 FY | 25.58 Billion JPY | -2.75% |
2004 FY | 26.3 Billion JPY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 48.75 Billion JPY | 49.147% |
Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 98.865% |
Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 86.811% |
Shionogi & Co., Ltd. | 369.08 Billion JPY | 93.283% |
Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -600.171% |
Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | 74.446% |
Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | 35.137% |
Eisai Co., Ltd. | 586.41 Billion JPY | 95.772% |
Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -313.338% |
Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | 68.606% |
Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | 52.387% |
Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | -83.413% |
Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -220.393% |
Tsumura & Co. | 68.81 Billion JPY | 63.974% |
Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | 33.606% |
Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | 69.537% |
Fuji Pharma Co., Ltd. | 16.51 Billion JPY | -50.118% |
Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | 50.595% |
KYORIN Holdings, Inc. | 51.4 Billion JPY | 51.767% |
Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -2197.683% |
Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -151.977% |
SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -462.048% |
MedRx Co., Ltd | 26 Million JPY | -95253.846% |
Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -208.907% |
Solasia Pharma K.K. | 337 Million JPY | -7256.677% |
Modalis Therapeutics Corporation | -731 Thousand JPY | 3391618.468% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | 19.152% |
Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | 54.359% |
Cyfuse Biomedical K.K. | 37.74 Million JPY | -65584.612% |
Toho Holdings Co., Ltd. | 112.98 Billion JPY | 78.057% |
Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -273.396% |